Eory Madera Miranda is a Puerto Rican-born entrepreneur, scientist, and founder of Truffle Temptations, a Miami-based luxury truffle brand bringing authentic Italian gourmet experiences to the U.S. market. With a Master’s degree in Pharmaceutical Science (Medicinal Chemistry) and over 15 years of experience in the biotech and pharmaceutical industries, she has built a career rooted in science, strategy, and innovation.
Her journey into the world of truffles began during her honeymoon in Italy, where she discovered the culture, craftsmanship, and luxury surrounding truffles. Inspired by that experience, she transformed a passion into a business—partnering directly with multigenerational producers in Italy to source the highest-quality truffle products.
Through Truffle Temptations, Eory blends wellness, education, and elevated culinary experiences, offering curated products, tastings, and community engagement across South Florida. Beyond her brand, she is also active in real estate investment and community leadership, continuously building ventures that reflect her commitment to quality, growth, and meaningful impact.
Industry
Food/Beverages
DOB
02/01/1985
Published Works
Treatment Patterns Among Patients with Rheumatoid Arthritis in Puerto Rico.
Rheumatology and Therapy · Jan 24, 2022Racial and ethnic disparities in rheumatoid arthritis (RA) have been identified in the United States, with higher levels of disease activity and worse functional status reported in Hispanic patients compared with their white counterparts. Although RA is one of the most prevalent health conditions in Puerto Rico, few studies have previously examined the characteristics or treatment patterns of patients receiving biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) in this population.Racial and ethnic disparities in rheumatoid arthritis (RA) have been identified in the United States, with higher levels of disease activity and worse functional status reported in Hispanic patients compared with their white counterparts. Although RA is one of the most prevalent health conditions in Puerto Rico, few studies have previously examined the characteristics or treatment patterns of patients receiving biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) in this population.
Patient characteristics, comorbidities, and infection outcomes among rheumatoid arthritis (ra) patients in puerto rico (pr)Patient characteristics, comorbidities, and infection outcomes among rheumatoid arthritis (ra) patients in puerto rico (pr)
Ann Rheum Dis, volume 79, supplement 1, year 2020, page 1422 · Jun 3, 2020Ann Rheum Dis, volume 79, supplement 1, year 2020, page 1422 · Jun 3, 2020
Cytotoxic screening of Thioredoxin Reductase inhibitors as a potential new anti-cancer drugsCytotoxic screening of Thioredoxin Reductase inhibitors as a potential new anti-cancer drug. XXX Annual Research Forum on Health Research and Education, UPR- Medical Sciences Campus, School of Pharmacy. Poster presentation · Jan 1, 2010
The development of new anti-cancer drugs that target and inhibit TrxR1 could prove to be a valuable chemotherapy tool. We hypothesized that rational-designed molecules containing a cyclic 1,2-disulfide unit as a pharmacophoric group will selectively block TrxR1 activity and will inhibit tumor growth in breast ccancancerer.
Cytotoxic screening of Thioredoxin Reductase inhibitors as a potential new anti-cancer drugs.Cytotoxic screening of Thioredoxin Reductase inhibitors as a potential new anti-cancer drugs.
American Association Cancer Research annual meeting, Washington DC. Poster presentation · Jan 1, 2010American Association Cancer Research annual meeting, Washington DC. Poster presentation · Jan 1, 2010The development of new anti-cancer drugs that target and inhibit TrxR1 could prove to be a valuable chemotherapy tool. We hypothesized that rational-designed molecules containing a cyclic 1,2-disulfide unit as a pharmacophoric group will selectively block TrxR1 activity and will inhibit tumor growth in breast cancer.
Synthesis of amino- benzodithiolane as Inhibitors of Thioredoxin reductase.Synthesis of amino- benzodithiolane as Inhibitors of Thioredoxin reductase.
Research forum: Bio-EXPO 2010, at UPR- Bayamon. · Jan 1, 2010Research forum: Bio-EXPO 2010, at UPR- Bayamon. · Jan 1, 2010The objective is to develop new benzodithiolane derivatives and compare the activity with benzodithiine derivatives that were previously synthesized and shown to inhibit the redox-enzyme thioredoxin reductase (TrxR). Inhibition of this enzyme by benzodithiin derivbatives has been shown to inhibit proliferation of cancer cells. Due to increased ring strain, the new benzodithiolanes are expected to be more reactive and more potent than benzodithiines.
Synthesis of 1,2 Cyclic Disulfides and 1,2 Cyclic thiosulfinates as Inhibitors of Thoredoxin Reductase.Synthesis of 1,2 Cyclic Disulfides and 1,2 Cyclic thiosulfinates as Inhibitors of Thoredoxin Reductase.
American Chemical Society- 61st Southeastern Regional Meeting 2009 (ACS- SERMACS).Convention Center Puerto Rico. Oral Presentation · Jan 1, 2009American Chemical Society- 61st Southeastern Regional Meeting 2009 (ACS- SERMACS).Convention Center Puerto Rico. Oral Presentation · Jan 1, 2009This work describes the synthesis of two novel classes of compounds that interfere with the activity of the redox-enzyme thioredoxin reductase and were shown to inhibit in vitro breast cancer cell growth. Breast cancer is the most commonly diagnosed form of cancer in women 40-55 years of age, and it is the second major cause of cancer deaths for women in the United States.
Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin Reducatse.Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin Reducatse.
XXIX Annual Research Forum on Health Research and Education, UPR-Medical Sciences Campus, School of Pharmacy. Poster presentation · Jan 1, 2009XXIX Annual Research Forum on Health Research and Education, UPR-Medical Sciences Campus, School of Pharmacy. Poster presentation · Jan 1, 2009The objective is to develop novel compounds that interfere with the redox-enzyme thioredoxin reductase. Inhibition of this enzyme has been shown to inhibit proliferation of cancer cells.
Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin reductase.Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin reductase.
American Association of Pharmaceuticals Scientists Annual Meeting, Los Angeles, California. Poster presentation · Jan 1, 2009American Association of Pharmaceuticals Scientists Annual Meeting, Los Angeles, California. Poster presentation · Jan 1, 2009The objective is to develop novel compounds that interfere with the redox-enzyme thioredoxin reductase. Inhibition of this enzyme has been shown to inhibit proliferation of cancer cells
Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin reductase.Synthesis of Cyclic Disulfides as Inhibitors of Thioredoxin reductase.
Program Steering Committee Meeting, Caribe Hilton, San Juan, PR. Poster presentation · Jan 1, 2009Program Steering Committee Meeting, Caribe Hilton, San Juan, PR. Poster presentation · Jan 1, 2009The objective is to develop novel compounds that interfere with the redox-enzyme thioredoxin reductase. Inhibition of this enzyme has been shown to inhibit proliferation of cancer cells
Effect of Reactive Oxygen Species (ROS) on the Acetylcholine and Potassium Chloride Induced Contraction of Rat Trachea in Conditions of Low TemperatureEffect of Reactive Oxygen Species (ROS) on the Acetylcholine and Potassium Chloride Induced Contraction of Rat Trachea in Conditions of Low Temperature
Forum, UPR-Medical Sciences Campus, School of Medicine. Poster presentation. · Jan 1, 2007Forum, UPR-Medical Sciences Campus, School of Medicine. Poster presentation. · Jan 1, 2007It has been observed that Reactive Oxygen Species (ROS) are of great importance in the etiology of several diseases that may be related to smooth muscle physiology.
Effect of Reactive Oxygen Species (ROS) on the Acetylcholine Induced Contraction of Rat Trachea in Conditions of Low TemperatureEffect of Reactive Oxygen Species (ROS) on the Acetylcholine Induced Contraction of Rat Trachea in Conditions of Low Temperature
Forum, UPR-Medical Sciences Campus, School of Medicine. Poster presentation. · Jan 1, 2006Forum, UPR-Medical Sciences Campus, School of Medicine. Poster presentation. · Jan 1, 2006Low temperature has been previously proven as a trigger for airway hyperactivity leading to asthma. It is also well known that asthma is related to an inflammatory response in the airways where reactive oxygen species are known to be generated. Although the physiological mechanisms of cold induced contraction have been studied, no association has been made between cold induced contraction and ROS.
My expertise lies at the intersection of science, strategy, and entrepreneurship. With more than 15 years of experience in the pharmaceutical and biotech industries, I have built a career translating complex scientific concepts into clear, actionable strategies that drive education, engagement, and growth. As a product developer, entrepreneur, and founder of Truffle Temptations, I have expanded this expertise into luxury retail, leading product sourcing, brand development, marketing, and business management. My passion is creating innovative, high-quality experiences that combine science, wellness, and consumer insights while building brands that connect authentically with their audiences.
M.S., Pharmacy, School of Pharmacy
BS- University of PR- General Sciences
Pharmacy Technician -Dewey University
·UPR-MDACC Clinical Trial Workshop, Scholarship Award (2009)
·The Big Ten+ Graduate School Expo scholarship by Purdue University (2009)
·1st Latin American Pharmacogenomics and Personalized Medicine Congress, Scholarship Award (2010)
· Rho Chi Society, UPR- MSC School of Pharmacy (2010)
Eory Madera Miranda is a Puerto Rican-born entrepreneur, scientist, and founder of Truffle Temptations, a Miami-based luxury truffle brand bringing authentic Italian gourmet experiences to the U.S. market. With a Master’s degree in Pharmaceutical Science (Medicinal Chemistry) and over 15 years of experience in the biotech and pharmaceutical industries, she has built a career rooted in science, strategy, and innovation.
Her journey into the world of truffles began during her honeymoon in Italy, where she discovered the culture, craftsmanship, and luxury surrounding truffles. Inspired by that experience, she transformed a passion into a business—partnering directly with multigenerational producers in Italy to source the highest-quality truffle products.
Through Truffle Temptations, Eory blends wellness, education, and elevated culinary experiences, offering curated products, tastings, and community engagement across South Florida. Beyond her brand, she is also active in real estate investment and community leadership, continuously building ventures that reflect her commitment to quality, growth, and meaningful impact.
